中华人民共和国制药业 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "中华人民共和国制药业" in Chinese language version.

refsWebsite

Global rank Chinese rank

40web.archive.org

1^st place

1^st place

2,255^th place

67^th place

low place

low place

447^th place

581^st place

2^nd place

23^rd place

low place

low place

343^rd place

13^th place

1chinadaily.com.cn

831^st place

134^th place

1worldwatch.org

low place

low place

1manufacturing.net

low place

low place

210^th place

353^rd place

1businesschina.org.sg

low place

low place

163^rd place

188^th place

low place

low place

1pharmaceuticalonline.com

low place

low place

68^th place

209^th place

4^th place

5^th place

5^th place

12^th place

731^st place

808^th place

low place

low place

7,882^nd place

312^th place

low place

low place

low place

low place

low place

low place

1fiercepharma.com

low place

low place

572^nd place

452^nd place

1researchgate.net

120^th place

337^th place

1astrazeneca.com.cn

low place

low place

1researchandmarkets.com

low place

low place

low place

417^th place

low place

low place

low place

low place

low place

low place

low place

low place

1cccmhpie.org.cn

low place

low place

1allianceboots.com

low place

low place

allianceboots.com

Alliance Boots to enter Chinese pharmaceutical market through joint venture （页面存档备份，存于互联网档案馆） 29 January 2007

astrazeneca.com.cn

en.astrazeneca.com.cn

存档副本. [2020-05-13]. （原始内容存档于2007-12-19）.

bajunfund.com

网站访问报错. bajunfund.com. [2017-03-27]. （原始内容存档于2017-03-27）.

businesschina.org.sg

存档副本. [2020-05-13]. （原始内容存档于2020-10-27）.

capc.org.cn

医药协会网 - 中国医药商业协会. www.capc.org.cn. [2020-05-13]. （原始内容存档于2020-10-28）.

cccmhpie.org.cn

中国医药保健品进出口商会. www.cccmhpie.org.cn. [2020-05-13]. （原始内容存档于2020-10-27）.

chinadaily.com.cn

于小明. Fast growth in China's pharmaceutical market to benefit foreign firms: report - Chinadaily.com.cn. www.chinadaily.com.cn. [2020-01-14]. （原始内容存档于2020-04-08）.

cpa.org.cn

中国药学会 >> 中国药学会联系方式, cpa.org.cn (Chinese Pharmaceutical Association), [2012-01-03], （原始内容存档于2010-12-04）（中文）

cq-m.com.cn

存档副本. [2020-05-13]. （原始内容存档于2020-08-19）.

doi.org

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu. Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study. PLOS ONE. 2016-10-25, 11 (10): e0165183. ISSN 1932-6203. PMC 5079602 . PMID 27780218. doi:10.1371/journal.pone.0165183 （英语）.
Yuanjia, Hu; Geng, Franny; Ying, Bian; Yitao, Wang. The Chinese pharmaceutical market: Perspectives of the health consumer. Journal of Medical Marketing. 2007-09-01, 7 (4): 295–300 [2020-05-13]. doi:10.1057/palgrave.jmm.5050099. （原始内容存档于2020-08-19）.

europa.eu

eudragmdp.ema.europa.eu

歐洲藥品管理機構不合規報告（页面存档备份，存于互联网档案馆）

fda.gov

accessdata.fda.gov

FDA不合规报告. [2020-05-13]. （原始内容存档于2020-10-21）.
Import Alert Industry Group Human Drug. www.accessdata.fda.gov. [2018-06-25]. （原始内容存档于2020-07-08）.

fda.gov

FDA警示. [2020-05-13]. （原始内容存档于2019-04-22）.
Warning Letters. www.fda.gov. [2018-06-25]. （原始内容存档于2019-04-22）.

fiercepharma.com

China's Jiangsu Hengrui in R&D effort with MD Anderson - FiercePharma. www.fiercepharma.com. [2020-05-13]. （原始内容存档于2020-07-07）.

ft.com

Dyer, Geoff, Novartis to open Shanghai research arm, Financial Times, 2006-11-05 [2012-01-03] ← No-charge registration required to reach this content.

google.com

Associated Press, IMS: China to be 3rd largest pharma market in 2011, Google News, 2010-03-16 [2012-01-03], （原始内容存档于2010-03-24）

google.com.tw

books.google.com.tw

China Medical and Pharmaceutical Industry Business Intelligence Report P. 57 (Barnet Siu; 2010) （页面存档备份，存于互联网档案馆）
China Medical and Pharmaceutical Industry Business Intelligence. IBP, Inc. : 75 [2021-02-01]. ISBN 978-1-4330-6130-1. （原始内容存档于2021-02-04）.
China Medical and Pharmaceutical Industry Business Intelligence. IBP, Inc. : 76 [2021-02-01]. ISBN 978-1-4330-6130-1. （原始内容存档于2021-02-04）.
China Medical and Pharmaceutical Industry Business Intelligence. IBP, Inc. : 57 [2021-02-01]. ISBN 978-1-4330-6130-1. （原始内容存档于2021-02-04）.
China Medical and Pharmaceutical Industry Business Intelligence Report, P. 72（Meng 2005 （页面存档备份，存于互联网档案馆）

hrs.com.cn

Archived copy. [2017-03-27]. （原始内容存档于2016-08-30）.
Archived copy. [2017-03-27]. （原始内容存档于2016-12-09）.

hrssd.com.cn

成都盛迪医药有限公司 - 成都盛迪医药有限公司. Hrssd.com.cn. [2018-06-25]. （原始内容存档于2020-10-24）.

incyte.com

Archived copy. [2017-03-27]. （原始内容存档于2016-06-21）.

jiemian.com

医药上市公司去年研发花了多少钱？恒瑞医药近12亿当上创新领头羊|界面新闻 · 证券. Jiemian.com. 2017-03-21 [2018-06-25]. （原始内容存档于2020-07-07）.

kanzhun.com

m.kanzhun.com

【泉州东南医药物流有限公司】泉州东南医药物流有限公司招聘-待遇-面试-怎么样-看准网. m.kanzhun.com.

manufacturing.net

Staff, China Could Be 3rd Largest Pharma Market By 2011, Manufacturing.net (news) (Advantage Business Media), 2010-03-16 [2012-01-03], （原始内容存档于2011-09-28）

nih.gov

ncbi.nlm.nih.gov

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu. Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study. PLOS ONE. 2016-10-25, 11 (10): e0165183. ISSN 1932-6203. PMC 5079602 . PMID 27780218. doi:10.1371/journal.pone.0165183 （英语）.

nongyekx.cn

read.nongyekx.cn

《中国医药机构志》吴正中主编；杨思澍，王明轩副主编北京：中国医药科技出版社 1992 第10页. [2022-01-12]. （原始内容存档于2022-01-12）.

pharmaceuticalonline.com

2017 FDA Warning Letters. pharmaceuticalonline. 2017 [2021-02-01]. （原始内容存档于2020-04-11）.

pmlive.com

GSK betting on China's healthcare growth. PMLiVE. 2012-03-13 [2012-05-24]. （原始内容存档于2020-10-30）.
Bayer expands research deal with university in China. PMLiVE. 2012-03-28 [2012-05-24]. （原始内容存档于2020-09-25）.
BMS signs cardiovascular research deal with China's Simcere. PMLiVE. 2011-12-14. ^{[失效連結]}
Merck pledges $1.5bn for China expansion. PMLiVE. 2011-12-06. ^{[失效連結]}
Lilly extends contract with Chinese CRO ShangPharma. PMLiVE. 2012-01-11 [2012-05-24]. （原始内容存档于2020-08-31）.

researchandmarkets.com

ltd, Research and Markets. Asian Animation, VFX & Games Industry: Strategies, Trends & Opportunities, 2018. www.researchandmarkets.com. [2020-05-13]. （原始内容存档于2011-09-28）.

researchgate.net

Chinese drug research. Novartis invests $100 million in Shanghai. American Association for the Advancement of Science. December 2006 [31 January 2021].

sagepub.com

journals.sagepub.com

Yuanjia, Hu; Geng, Franny; Ying, Bian; Yitao, Wang. The Chinese pharmaceutical market: Perspectives of the health consumer. Journal of Medical Marketing. 2007-09-01, 7 (4): 295–300 [2020-05-13]. doi:10.1057/palgrave.jmm.5050099. （原始内容存档于2020-08-19）.

sec.gov

AXM Pharma, Inc. 10-KSB for 12/31/04. www.sec.gov. [2020-05-13]. （原始内容存档于2020-08-19）.

sohu.com

mt.sohu.com

上市药企研发投入50强,有你家吗?. mt.sohu.com. 2016-07-14 [2020-05-13]. （原始内容存档于2017-03-27）.

health.sohu.com

诺和诺德研发中心落户中关村生命科学园-搜狐健康. health.sohu.com. [2020-05-13]. （原始内容存档于2020-08-19）.

tesarobio.com

ir.tesarobio.com

Archived copy. [2017-03-27]. （原始内容存档于2017-03-27）.

web.archive.org

于小明. Fast growth in China's pharmaceutical market to benefit foreign firms: report - Chinadaily.com.cn. www.chinadaily.com.cn. [2020-01-14]. （原始内容存档于2020-04-08）.
unknown, China's Pharmaceutical Industry Lacks Innovation, Lags Behind, China Watch (Washington, D.C., United States: Worldwatch Institute), n.d., worldwatch.org [2012-01-03], （原始内容存档于2012-02-11）
Staff, China Could Be 3rd Largest Pharma Market By 2011, Manufacturing.net (news) (Advantage Business Media), 2010-03-16 [2012-01-03], （原始内容存档于2011-09-28）
存档副本. [2020-05-13]. （原始内容存档于2020-10-27）.
Associated Press, IMS: China to be 3rd largest pharma market in 2011, Google News, 2010-03-16 [2012-01-03], （原始内容存档于2010-03-24）
China Medical and Pharmaceutical Industry Business Intelligence Report P. 57 (Barnet Siu; 2010) （页面存档备份，存于互联网档案馆）
中国药学会 >> 中国药学会联系方式, cpa.org.cn (Chinese Pharmaceutical Association), [2012-01-03], （原始内容存档于2010-12-04）（中文）
2017 FDA Warning Letters. pharmaceuticalonline. 2017 [2021-02-01]. （原始内容存档于2020-04-11）.
FDA不合规报告. [2020-05-13]. （原始内容存档于2020-10-21）.
歐洲藥品管理機構不合規報告（页面存档备份，存于互联网档案馆）
FDA警示. [2020-05-13]. （原始内容存档于2019-04-22）.
China Medical and Pharmaceutical Industry Business Intelligence. IBP, Inc. : 75 [2021-02-01]. ISBN 978-1-4330-6130-1. （原始内容存档于2021-02-04）.
China Medical and Pharmaceutical Industry Business Intelligence. IBP, Inc. : 76 [2021-02-01]. ISBN 978-1-4330-6130-1. （原始内容存档于2021-02-04）.
China Medical and Pharmaceutical Industry Business Intelligence. IBP, Inc. : 57 [2021-02-01]. ISBN 978-1-4330-6130-1. （原始内容存档于2021-02-04）.
Yuanjia, Hu; Geng, Franny; Ying, Bian; Yitao, Wang. The Chinese pharmaceutical market: Perspectives of the health consumer. Journal of Medical Marketing. 2007-09-01, 7 (4): 295–300 [2020-05-13]. doi:10.1057/palgrave.jmm.5050099. （原始内容存档于2020-08-19）.
GSK betting on China's healthcare growth. PMLiVE. 2012-03-13 [2012-05-24]. （原始内容存档于2020-10-30）.
Bayer expands research deal with university in China. PMLiVE. 2012-03-28 [2012-05-24]. （原始内容存档于2020-09-25）.
Lilly extends contract with Chinese CRO ShangPharma. PMLiVE. 2012-01-11 [2012-05-24]. （原始内容存档于2020-08-31）.
Archived copy. [2017-03-27]. （原始内容存档于2016-08-30）.
成都盛迪医药有限公司 - 成都盛迪医药有限公司. Hrssd.com.cn. [2018-06-25]. （原始内容存档于2020-10-24）.
医药上市公司去年研发花了多少钱？恒瑞医药近12亿当上创新领头羊|界面新闻 · 证券. Jiemian.com. 2017-03-21 [2018-06-25]. （原始内容存档于2020-07-07）.
上市药企研发投入50强,有你家吗?. mt.sohu.com. 2016-07-14 [2020-05-13]. （原始内容存档于2017-03-27）.
网站访问报错. bajunfund.com. [2017-03-27]. （原始内容存档于2017-03-27）.
Archived copy. [2017-03-27]. （原始内容存档于2016-12-09）.
Archived copy. [2017-03-27]. （原始内容存档于2016-06-21）.
Archived copy. [2017-03-27]. （原始内容存档于2017-03-27）.
China's Jiangsu Hengrui in R&D effort with MD Anderson - FiercePharma. www.fiercepharma.com. [2020-05-13]. （原始内容存档于2020-07-07）.
AXM Pharma, Inc. 10-KSB for 12/31/04. www.sec.gov. [2020-05-13]. （原始内容存档于2020-08-19）.
存档副本. [2020-05-13]. （原始内容存档于2007-12-19）.
诺和诺德研发中心落户中关村生命科学园-搜狐健康. health.sohu.com. [2020-05-13]. （原始内容存档于2020-08-19）.
ltd, Research and Markets. Asian Animation, VFX & Games Industry: Strategies, Trends & Opportunities, 2018. www.researchandmarkets.com. [2020-05-13]. （原始内容存档于2011-09-28）.
《中国医药机构志》吴正中主编；杨思澍，王明轩副主编北京：中国医药科技出版社 1992 第10页. [2022-01-12]. （原始内容存档于2022-01-12）.
Warning Letters. www.fda.gov. [2018-06-25]. （原始内容存档于2019-04-22）.
Import Alert Industry Group Human Drug. www.accessdata.fda.gov. [2018-06-25]. （原始内容存档于2020-07-08）.
江苏亚邦医药物流中心有限公司-首页. www.yabyy.com. [2020-05-13]. （原始内容存档于2020-08-19）.
存档副本. [2020-05-13]. （原始内容存档于2020-08-19）.
医药协会网 - 中国医药商业协会. www.capc.org.cn. [2020-05-13]. （原始内容存档于2020-10-28）.
中国医药保健品进出口商会. www.cccmhpie.org.cn. [2020-05-13]. （原始内容存档于2020-10-27）.
China Medical and Pharmaceutical Industry Business Intelligence Report, P. 72（Meng 2005 （页面存档备份，存于互联网档案馆）
Alliance Boots to enter Chinese pharmaceutical market through joint venture （页面存档备份，存于互联网档案馆） 29 January 2007

worldcat.org

Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu. Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study. PLOS ONE. 2016-10-25, 11 (10): e0165183. ISSN 1932-6203. PMC 5079602 . PMID 27780218. doi:10.1371/journal.pone.0165183 （英语）.

worldwatch.org

unknown, China's Pharmaceutical Industry Lacks Innovation, Lags Behind, China Watch (Washington, D.C., United States: Worldwatch Institute), n.d., worldwatch.org [2012-01-03], （原始内容存档于2012-02-11）

yabyy.com

江苏亚邦医药物流中心有限公司-首页. www.yabyy.com. [2020-05-13]. （原始内容存档于2020-08-19）.